Abstract
Background
The assessment of prostate weight as a determinant of a high prostate margin rate after laparoscopic radical prostatectomy has not been studied.
Methods
Prospective pathologic findings of 1,500 patients who underwent laparoscopic radical prostatectomy (LRP, 399 cases) and da VinciTM prostatectomy (DVP, 1,101 cases) between December 2000 to June 2006 at City of Hope National Medical Center were evaluated. Gleason score, pathologic stage, the presence or absence of positive margins, extraprostatic tumor extension, and seminal vesicle involvement by tumor were recorded in all patients. Preoperational serum prostate specific antigen (PSA) levels were recorded in all but 13 cases. These parameters were then correlated with prostate weight.
Results
Of 1,500 patients, 345 had one or more positive margins (23%). Patients with low median prostate weight (49 g) had a significantly higher positive margin rate (p < 0.0001) and incidence of extraprostatic extension by tumor (p = 0.04), and were 1.523 times more likely to have positive margins [95% confidence interval (CI) 1.167–1.985].
Conclusion
We conclude that low prostate weight may be a determinant of a higher recurrence rate and more aggressive disease.
Similar content being viewed by others
References
Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Busch C, Nordling S, Garmo H (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1877–1984
Lepor H (2005) Open versus laparoscopic radical prostatectomy. Rev In Urol 7:115–127
Salomon L, Sebe P, de la Taille A, Vordos D, Hoznek A, Yiou R, Chopin D, Abbou CC (2004) Open versus laparoscopic radical prostatectomy: part I. BJU Int 94(2):238–243
Sofer M, Hamilton-Nelson KL, Civantos F, Soloway MS (2002) Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression. J Urol 167(6):2453–2456
Humphreys MR, Gettman MT, Chow GK, Zincke H, Blute ML (2004) Minimally invasive radical prostatectomy. Mayo Clin Proc 79(9):1169–1180
Watson RB, Civantos F, Soloway MS (1996) Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology 48(1):80–90
Obek C, Sadek S, Lai S, Civantos F, Rubinowicz D, Soloway MS (1999) Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology 54(4):682–688
El Feel A, Davis JW, Deger S, Roigas J, Wille AH, Schnorr D, Hakiem AA, Loening S, Tuerk IA (2003) Positive margins after laparoscopic radical prostatectomy: a prospective study of 100 cases performed by 4 different surgeons. Eur Urol 43(6):622–626
Chang CM, Moon D, Gianduzzo TR, Eden CG (2005) The impact of prostate size in laparoscopic radical prostatectomy. Eur Urol 48(2):285–290
Rodriguez AR, Kapoor R, Pow-Sang JM (2007) Laparoscopic extraperitoneal radical prostatectomy in complex surgical cases. J Urol 177(5):1765–1770
Boczko J, Erturk E, Golijanin D, Madeb R, Patel H, Joseph JV (2007) Impact of prostate size in robot-assisted radical prostatectomy. J Endourol 21(2):184–188
Freedland SJ, Isaacs WB, Platz EA, Terris MK, Aronson WJ, Amling CL, Presti JC, Kane CJ (2005) Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 23:7546–7554
Chodak GW, Vogelzang NJ, Caplan RJ (1991) Independent prognostic factors in patients with metastatic (stage D2) prostate cancer: the Zoladex Study Group. JAMA 265:618–621
Oefelein MG, Agarwai PK, Resnick MI (2004) Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era. J Urol 171:1525–1528
Massengill JC, Sun L Moul JW (2003) Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 169:1670–1675
Catalona WJ, Smith DS (1998) Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 160(6 pt 2):2428–2434
Huland H (2001) Radical prostatectomy: options and issues. Eur Urol 39(Suppl 1):3–9
Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28(3):555–565
Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT (2002) Cancer control with radical prostatectomy alone in 1, 000 consecutive patients. J Urol 167(2 pt 1):528–534
Salomon L, Levrel O, de la Taille A, Anastasiadis AG, Saint F, Zaki S, Vordos D, Cicco A, Olsson LE, Hoznek A, Chopin D, Abbou CC (2002) Radical prostatectomy by the retropubic, perineal and laparoscopic approach: 12 years of experience in one center. Eur Urol 42(2):104–110
Harris MJ (2003) Radical perineal prostatectomy: cost efficient, outcome effective, minimally invasive prostate cancer management. Eur Urol 44(3):303–308
Jones EC (1990) Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade and local tumor extension. J Urol 144:89–93
Rassweiler J, Seemann O, Schulze M, Teber D, Hatzinger M, Frede T (2003) Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol 169(5):1689–1693
Blute ML, Bostwick DG, Bergstralh EJ, Slezak JM, Martin SK, Amling CL, Zincke H (1997) Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urol 50:733–739
Roumeguere T, Bollens R, vanden Bossche M (2003) Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approaches. World J Urol 20:360–366
Guillonneau B, el-Fettouh H, Haumert H, Cathelineau X, Doublet JD, Fromont G (2003) Laparoscopic radical prostatectomy: oncological evaluation after 1, 000 cases at Montsouris Institute. J Urol 169:1261–1266
Stolzenburg JU, Rabenalt R, Do M, Truss MC, Burchardt M, Herrmann TR, Schwalenberg T, Kallidonis P, Liatsikos EN (2007) Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 1, 300 cases. World J Urol 25(1):45–51
Brown JA, Garlitz C, Strup SE, Hubosky SG, Gomella L (2004) Laparoscopic radical prostatectomy after neoadjuvant hormonal therapy: an apparently safe and effective procedure. J Laparoendosc Adv Sur Tech A 14:335–338
Aus G, Abrahamsson P, Ahlgren G (1998) Hormonal treatment before radical prostatectomy: a 3-year followup. J Urol 159:2013–2016
Schulman CC, Debruyne FMJ, Foster G, Selvaggi FP, Zlotta AR, Witjes WP (2000) 4-Year follow-up results of a european prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T3N0M0 prostate cancer. Eur Urol 38:706–713
Soloway MS, Pareek K, Sharifi R, Wajsman Z, McLeod D, Wood DP Jr, Puras-Baez A (2002) Neoadjuvant androgen ablation before radical prostatectomy in CT2bNxM0 prostate cancer: 5-year results. J Urol 167:112–116
Prezioso D, Lotti T, Polito M, Montironi R (2004) Neoadjuvant hormone treatment with leuprolide acetate depot 3.75 Mg and cyproterone acetate, before radical prostatectomy: a randomized study. Urol Int 72:189–195
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chu, P.G., Lau, S.K., Weiss, L.M. et al. Assessment of low prostate weight as a determinant of a higher positive margin rate after laparoscopic radical prostatectomy: a prospective pathologic study of 1,500 cases. Surg Endosc 23, 1058–1064 (2009). https://doi.org/10.1007/s00464-008-0131-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-008-0131-6